Medicine
Rivaroxaban 2.5 mg tablet
Rivaroxaban 2.5 mg tablet is a generic prescription medicine for oral use, made by 17 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Key facts
- Active ingredient (INN)
- Rivaroxaban
- Brand
- Sold under the generic name
- Strength
- 2.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 blister pack, 180 tablets, 60 tablets and 45 more
- Manufacturers
- Alembic PharmaceuticalsIndiaLifestar PharmaIndiaNovadoz PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaIndoco RemediesIndiaMacleods PharmaceuticalsIndiaMicro LabsIndiaAurobindo PharmaIndiaCamber PharmaceuticalsIndiaLupinIndia17 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B01AF01 Rivaroxaban
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 March 2025
- Identifiers
- RxCUI 1114198, 1232082, 1232086 +2DailyMed set ID e62f23c6-89f2-4179-95dc-5732401b3f93, d6de1719-6fbd-4386-9f81-d65980dc4bd8, 5524f30f-789d-4f5c-8f7c-d03a475b6d34 +15NDC 62332-683, 70756-006, 46708-683 +15Application ANDA210301, ANDA220874, ANDA208555 +10
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 17 labelers. The register lists 48 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 46708-683-10 | Alembic PharmaceuticalsIndia | 14 May 2025 |
| 180 tablet, film coated in 1 bottle | 46708-683-45 | Alembic PharmaceuticalsIndia | 14 May 2025 |
| 60 tablet, film coated in 1 bottle | 46708-683-60 | Alembic PharmaceuticalsIndia | 14 May 2025 |
| 1000 tablet, film coated in 1 bottle | 46708-683-91 | Alembic PharmaceuticalsIndia | 14 May 2025 |
| 100 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 62332-683-10 | Alembic PharmaceuticalsIndia | 14 May 2025 |
| 180 tablet, film coated in 1 bottle | 62332-683-45 | Alembic PharmaceuticalsIndia | 14 May 2025 |
| 60 tablet, film coated in 1 bottle | 62332-683-60 | Alembic PharmaceuticalsIndia | 14 May 2025 |
| 1000 tablet, film coated in 1 bottle | 62332-683-91 | Alembic PharmaceuticalsIndia | 14 May 2025 |
| 180 tablet, film coated in 1 bottle | 59651-849-18 | Aurobindo PharmaIndia | 10 April 2025 |
| 60 tablet, film coated in 1 bottle | 59651-849-60 | Aurobindo PharmaIndia | 10 April 2025 |
| 180 tablet, film coated in 1 bottle | 31722-496-18 | Camber PharmaceuticalsIndia | 20 May 2025 |
| 60 tablet, film coated in 1 bottle | 31722-496-60 | Camber PharmaceuticalsIndia | 20 May 2025 |
| 180 tablet in 1 bottle | 43598-981-18 | Dr. Reddy's LaboratoriesIndia | 14 May 2025 |
| 60 tablet in 1 bottle | 43598-981-60 | Dr. Reddy's LaboratoriesIndia | 14 May 2025 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 43598-981-78 | Dr. Reddy's LaboratoriesIndia | 14 May 2025 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 14445-147-10 | Indoco RemediesIndia | 11 August 2025 |
| 180 tablet, film coated in 1 bottle | 14445-147-18 | Indoco RemediesIndia | 11 August 2025 |
| 60 tablet, film coated in 1 bottle | 14445-147-60 | Indoco RemediesIndia | 11 August 2025 |
| 1000 tablet in 1 bottle | 70756-006-12 | Lifestar PharmaIndia | 1 October 2026 |
| 60 tablet in 1 bottle | 70756-006-60 | Lifestar PharmaIndia | 1 October 2026 |
| 180 tablet in 1 bottle | 70756-006-81 | Lifestar PharmaIndia | 1 October 2026 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 70756-006-99 | Lifestar PharmaIndia | 1 October 2026 |
| 30 tablet, film coated in 1 bottle | 68180-709-06 | LupinIndia | 6 March 2025 |
| 90 tablet, film coated in 1 bottle | 68180-709-09 | LupinIndia | 6 March 2025 |
| 60 tablet, film coated in 1 bottle | 33342-488-09 | Macleods PharmaceuticalsIndia | 14 May 2025 |
| 180 tablet, film coated in 1 bottle | 33342-488-57 | Macleods PharmaceuticalsIndia | 14 May 2025 |
| 10 blister pack in 1 carton / 6 tablet, film coated in 1 blister pack | 33342-488-98 | Macleods PharmaceuticalsIndia | 14 May 2025 |
| 500 tablet in 1 bottle | 42571-345-05 | Micro LabsIndia | 6 July 2026 |
| 30 tablet in 1 bottle | 42571-345-30 | Micro LabsIndia | 6 July 2026 |
| 60 tablet in 1 bottle | 42571-345-60 | Micro LabsIndia | 6 July 2026 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 72205-416-02 | Novadoz PharmaceuticalsIndia | 18 March 2026 |
| 30 tablet, film coated in 1 bottle | 72205-416-03 | Novadoz PharmaceuticalsIndia | 18 March 2026 |
| 60 tablet, film coated in 1 bottle | 72205-416-04 | Novadoz PharmaceuticalsIndia | 18 March 2026 |
| 180 tablet, film coated in 1 bottle | 72205-416-05 | Novadoz PharmaceuticalsIndia | 18 March 2026 |
| 60 tablet, coated in 1 bottle | 51672-4228-4 | Sun Pharmaceutical IndustriesIndia | 15 October 2025 |
| 180 tablet, coated in 1 bottle | 51672-4228-9 | Sun Pharmaceutical IndustriesIndia | 15 October 2025 |
| 500 tablet, film coated in 1 bottle | 60505-6256-5 | Apotex | 2 May 2025 |
| 60 tablet, film coated in 1 bottle | 60505-6256-6 | Apotex | 2 May 2025 |
| 180 tablet, film coated in 1 bottle | 76282-774-18 | Exelan pharmaceuticals,Inc | 4 August 2025 |
| 60 tablet, film coated in 1 bottle | 76282-774-60 | Exelan pharmaceuticals,Inc | 4 August 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Rivaroxaban 2.5 mg tablet.
Other strengths and forms of Rivaroxaban
Clinical summary
Rivaroxaban is a factor Xa inhibitor. It is available as tablets, oral suspension and kits. MedsAcross supplies Rivaroxaban for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RivaroxabanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Xarelto prescribing information (Janssen Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Xarelto: European public assessment report (EPAR) · European Medicines Agency
- Rivaroxaban Accord: European public assessment report (EPAR) · European Medicines Agency
Need Rivaroxaban 2.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.